Philips posted strong headline results and raised its EBITA and cash flow outlook on a one-off US tariff refund. However, beneath the headline, diagnosis and treatment profitability weakened, order intake turned negative, and growth shifted away from core markets. Shares fell 9% on the news.
Philips is the first to market with its helium-free 3.0T MR, which should help it recover some market share losses following its supply chain issues.
China's return to prominence is highly uncertain. Philips has an outsize exposure to this market, both in imaging and personal health.
|
Metric
|
PHIA
|
RMD
|
SHL
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.77 | 17.51 | 18.25 |
Price/Book Value | 1.95 | 4.38 | 2.31 |
Price/Sales | 1.27 | 5.05 | 1.91 |
Price/Cash Flow | 8.84 | 15.19 | 13.84 |
|
Metric
|
PHIA
|
RMD
|
SHL
|
|---|---|---|---|
Quick Ratio | 0.73 | 2.00 | 0.74 |
Current Ratio | 1.26 | 3.01 | 1.16 |
Interest Coverage | 5.51 | — | 7.88 |
|
Metric
|
PHIA
|
RMD
|
SHL
|
|---|---|---|---|
Return on Assets (Normalized) | 6.09% | — | 5.00% |
Return on Equity (Normalized) | 14.83% | — | 12.25% |
Return on Invested Capital (Normalized) | 9.41% | — | 12.99% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|tH%G?!k | LOCK|<XFq$ | $187B | |||
| Stryker Corp
SYK
| LOCK|r%T?!!% | LOCK|^@m | $130B | |||
| Medtronic PLC
MDT
| LOCK|#%$^?D | LOCK|rvzL | $112B | |||
| Boston Scientific Corp
BSX
| LOCK|nW#s@% | LOCK|Bt!y | $71B | |||
| Edwards Lifesciences Corp
EW
| LOCK|^xpcz!T | LOCK|$%^^ | $52B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|F!J%BD | LOCK|Z!> | $32B | |||
| DexCom Inc
DXCM
| LOCK|wd!!b!zn | LOCK|SJ^B | $32B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Rkh | LOCK|C&f | $26B | |||
| Steris PLC
STE
| LOCK|ZgRf#G | LOCK|KQXnR | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|b<Ngw$xJ | LOCK|ftS | $18B |
United States